Metraipolis › archive › dc_fdbfd7201c36

Target discovery and drug design in the era of artificial intelligence — Europe PMC PMID:42446537

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42446537
DOI
10.1007/s00044-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-08T14:26:39.707Z
SHA-256 of the archived text
ed18f606807622d508f9cc02b5fddca0c8d8dfa2a59569c147bbaad55adb08b6
Stable URL of this page
https://metraipolis.com/documento/dc_fdbfd7201c36

How to cite

Target discovery and drug design in the era of artificial intelligence — Europe PMC PMID:42446537 — Europe PMC (en), https://europepmc.org/article/MED/42446537 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdbfd7201c36 (Metraipolis archive dc_fdbfd7201c36, sha256 ed18f606807622d508f9cc02b5fddca0c8d8dfa2a59569c147bbaad55adb08b6)
BibTeX
@misc{dcfdbfd7201c36,
  title = {Target discovery and drug design in the era of artificial intelligence — Europe PMC PMID:42446537},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42446537},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdbfd7201c36; sha256 ed18f606807622d508f9cc02b5fddca0c8d8dfa2a59569c147bbaad55adb08b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42446537. Agents can read the archived copy with the MCP tool read_document.